This inventor holds 3 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignee: Alseres Pharmaceuticals, Inc.. Active years: 2013-2017.
Company Filing History:
Years Active: 2013-2017
Title: The Innovative Contributions of David Leyh
Introduction
David Leyh is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of diagnostics, particularly in formulations that aid in the diagnosis of neurological conditions. With a total of 3 patents to his name, Leyh's work exemplifies the intersection of science and innovation.
Latest Patents
One of Leyh's latest patents is a labeled iodinated tropane formulation. This diagnostic formulation comprises a tropane with a radioactive concentration of at least 1.6 mCi/mL, maintained for at least about 51 hours post-creation. The formulation optionally includes a radiolabeled dopamine transporter (DAT) ligand, which is useful in diagnosing Parkinson's disease. An example of such a ligand is [I]-2β-carbomethoxy-3β-(4-fluorophenyl)-N-(3-iodo-E-allyl)nortropane. This innovative approach has the potential to enhance diagnostic accuracy and patient outcomes.
Career Highlights
Throughout his career, David Leyh has worked with several companies, including Alseres Pharmaceuticals, Inc. and Likeminds, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical diagnostics.
Collaborations
Leyh has collaborated with various professionals in his field, including Chris Sterzinger and Cara Ferreira. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions.
Conclusion
David Leyh's contributions to the field of diagnostics through his innovative patents highlight his role as a significant inventor. His work not only advances medical science but also improves the quality of life for patients.